Sanofi is one of the world's top producers of insulin, and the China market for treatment of the illness is huge: Some 140 ...

French pharma giant Sanofi will invest some 1 billion euros ($1.05 billion) to establish a new insulin production base in ...

Sanofi’s latest capital outlay in China will cover the development of a new insulin plant in the nation’s capital.

Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...

The French pharma firm is seeking to increase insulin production in Beijing as trade tensions between the EU and China simmer ...

The China-based subsidiary of French pharma major Sanofi revealed it has signed a memorandum of cooperation with Beijing ...

French drug major Sanofi plans to invest around 1 billion euros or about $1.05 billion to build a new insulin manufacturing base in ...

Sanofi a leading global healthcare company invests ampeuro1 billion in Beijing for a new insulin plant creating jobs and bolstering China health ...

Chinese Vice Premier He Lifeng also a member of the Political Bureau of the Communist Party of China Central Commit ...

The Chinese government's policies promoting opening up and innovation, as well as the excellent business environment it fosters for foreign enterprises, have injected strong confidence into Sanofi's ...

Despite the growing complexity of economic and trade relations between China and the EU, European companies remain steadfast ...

The Chinese Ministry of Commerce said Tuesday that it will ban exports of so-called dual-use materials to the U.S. for military purposes. The restriction applies to gallium, germanium, antimony and ...